7 results on '"Kitami, C."'
Search Results
2. Surgery for Recurrent Biliary Tract Cancer: A Multicenter Analysis
- Author
-
Sakata, J., primary, Nomura, T., additional, Aono, T., additional, Kitami, C., additional, Yokoyama, N., additional, Minagawa, M., additional, Takizawa, K., additional, Miura, K., additional, Ishikawa, H., additional, Hirose, Y., additional, Mito, M., additional, Saito, S., additional, Abe, S., additional, Ichikawa, H., additional, Shimada, Y., additional, Kobayashi, T., additional, and Wakai, T., additional
- Published
- 2022
- Full Text
- View/download PDF
3. Surgical Outcomes of Primary Cystic Duct Carcinoma: A Multi-Institutional Analysis
- Author
-
Abe, S., primary, Sakata, J., additional, Kitami, C., additional, Minagawa, M., additional, Nomura, T., additional, Yokoyama, N., additional, Aono, T., additional, Takizawa, K., additional, Miura, K., additional, Ishikawa, H., additional, Hirose, Y., additional, Mito, M., additional, Saito, S., additional, Ichikawa, H., additional, Shimada, Y., additional, Kobayashi, T., additional, and Wakai, T., additional
- Published
- 2022
- Full Text
- View/download PDF
4. Combined pancreaticoduodenectomy for advanced gallbladder cancer: Indications, surgical outcomes, and limitations.
- Author
-
Miura Y, Sakata J, Nomura T, Takano K, Kitami C, Aono T, Tsukahara A, Ohashi T, Takizawa K, Miura K, Hirose Y, Abe S, Kawachi Y, Kobayashi T, Ichikawa H, Shimada Y, and Wakai T
- Abstract
Background: This study aimed to elucidate the clinical value of combined pancreaticoduodenectomy (PD) for advanced gallbladder cancer according to the mode of cancer spread in the pancreaticoduodenal region., Methods: Patients who underwent combined PD for advanced gallbladder cancer were retrospectively reviewed. The mode of cancer spread in the pancreaticoduodenal region was defined as involvement of peripancreatic organs/structures alone, peripancreatic nodal metastasis alone, or both. Surgical outcomes were compared among these modes of spread., Results: Fifty-seven patients were included. Rates of severe morbidity and mortality were 52.6% and 3.5%, respectively. The mode of cancer spread was involvement of peripancreatic organs/structures alone in 16 patients, peripancreatic nodal metastasis alone in 17, and both in 24; R0 resection rates differed significantly among the groups (87.5% vs. 94.1% vs. 37.5%; p < 0.001). Overall survival (OS) was significantly worse in patients with both modes of spread (5-year OS, 8.3%) than in those with involvement of peripancreatic organs/structures alone (5-year OS, 37.9%; p < 0.001) and those with peripancreatic nodal metastasis alone (5-year OS, 29.4%; p = 0.011). OS was similar between pM0 patients with both modes of spread and pM1 patients (5-year OS, 16.7% vs. 8.7%; p = 0.605). Multivariate analysis identified mode of cancer spread as an independent prognostic factor (p = 0.006)., Conclusions: Combined PD could be oncologically justified for advanced gallbladder cancer with involvement of peripancreatic organs/structures alone or peripancreatic nodal metastasis alone in the pancreaticoduodenal region. This procedure would not be indicated in patients with both modes of spread., Competing Interests: Declaration of competing interest No specific funding was received for this study and the authors have no conflicts of interest to disclose., (Copyright © 2024 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
5. Extent of regional lymphadenectomy and number-based nodal classification for non-ampullary duodenal adenocarcinoma.
- Author
-
Abe S, Sakata J, Hirose Y, Nomura T, Takano K, Kitami C, Yokoyama N, Aono T, Minagawa M, Tsukahara A, Ohashi T, Takizawa K, Miura K, Ichikawa H, Shimada Y, Kobayashi T, and Wakai T
- Subjects
- Humans, Neoplasm Staging, Lymph Node Excision, Prognosis, Lymph Nodes surgery, Lymph Nodes pathology, Adenocarcinoma surgery, Adenocarcinoma pathology, Duodenal Neoplasms surgery, Duodenal Neoplasms pathology
- Abstract
Background: This study aimed to evaluate the adequate extent of regional lymphadenectomy according to tumor location and the impact of number-based nodal classification on survival in patients with non-ampullary duodenal adenocarcinoma (NADAC)., Methods: A total of 85 patients with NADAC who underwent surgery were enrolled. The frequency of metastasis was calculated for each node group in the respective tumor locations for 63 patients who underwent lymphadenectomy for pT2-pT4 tumor., Results: The frequency of metastasis in the pancreaticoduodenal (nos. 13 and 17) and superior mesenteric artery (no. 14) nodes was high (16.7 %-52.3 %) regardless of tumor location. Metastasis in the perigastric (nos. 3 and 4d) and right celiac artery (no. 9) nodes was not uncommon (14.3 %-22.2 %) for tumors in the first portion. The frequency of metastasis in the pyloric (nos. 5 and 6) and the other peripancreaticoduodenal (nos. 8 and 12) nodes varied depending on tumor location but could not be ignored for staging. When these nodes were classified as regional nodes, the 5-year survival in patients with pN0, pN1 (1-2 positive nodes), and pN2 (≥3 positive nodes) were 82.9 %, 51.7 %, and 19.2 %, respectively (p < 0.001). pN classification independently predicted survival (pN1, p = 0.022; pN2, p < 0.001)., Conclusions: Nos. 5, 6, 8, 12, 13, 14, and 17 nodes in all advanced NADAC and nos. 3, 4d, and 9 nodes in advanced NADAC in the first portion should be considered as regional nodes for accurate staging. The number-based nodal classification allows good patients' prognostic stratification., (© 2023 Published by Elsevier Ltd.)
- Published
- 2023
- Full Text
- View/download PDF
6. Outcomes of lung metastasis from pancreatic cancer: A nationwide multicenter analysis.
- Author
-
Homma Y, Endo I, Matsuyama R, Sho M, Mizuno S, Seyama Y, Hirano S, Aono T, Kitami C, Morita Y, Takeda Y, Yoshida K, Tani M, Kaiho T, Yamamoto Y, Aoki H, Ogawa M, Niguma T, Mataki Y, Kawasaki H, Baba H, Yokomizo H, Rikiyama T, Yamaue H, and Yamamoto M
- Subjects
- Humans, Neoplasm Recurrence, Local surgery, Pancreatectomy, Prognosis, Retrospective Studies, Survival Rate, Pancreatic Neoplasms, Carcinoma, Pancreatic Ductal drug therapy, Carcinoma, Pancreatic Ductal surgery, Liver Neoplasms surgery, Lung Neoplasms secondary, Lung Neoplasms surgery, Pancreatic Neoplasms pathology
- Abstract
Background: Although distant metastasis from pancreatic ductal adenocarcinoma (PDAC) has a dismal prognosis, some single center studies reported that lung metastasis has a favorable prognosis. The aim of this study is to evaluate the prognostic value of site-specific metastasis after pancreatectomy for PDAC, with a focus on lung metastasis., Methods: Data from 117 cases of lung metastasis after pancreatectomy were collected retrospectively from 23 institutions in Japan. To compare the sites of metastasis we also collected the data of 134 patients with liver only metastasis, 67 patients with peritoneal only metastasis and 121 patients with locoregional recurrence alone., Results: In patients with lung only metastasis, the median time from recurrence to death (RTD) was 23.1 months, which was better in comparison to other sites of recurrence. In lung metastasis group, the patients who underwent pulmonary resection had better long-term outcomes in comparison to those who did not. (RTD: 29.2 vs 15.2, P < .001). In the multivariate analysis, solitary metastasis (HR 5.03; 95% CI 1.195-21.144, P = .022) and postoperative chemotherapy (HR 14.089; 95% CI 1.729-114.77, P = .023) were identified as significant prognostic factors after lung resection., Conclusions: Surgical resection is a favorable option for selected patients with a solitary lung metastasis and for whom adjuvant chemotherapy can be administrated., (© 2022 Japanese Society of Hepato-Biliary-Pancreatic Surgery.)
- Published
- 2022
- Full Text
- View/download PDF
7. Oncological outcomes of surgery for recurrent biliary tract cancer: who are the best candidates?
- Author
-
Sakata J, Nomura T, Aono T, Kitami C, Yokoyama N, Minagawa M, Takizawa K, Miura K, Hirose Y, Ichikawa H, Nagahashi M, Shimada Y, Kobayashi T, and Wakai T
- Subjects
- Bile Ducts, Intrahepatic, Humans, Neoplasm Recurrence, Local, Prognosis, Retrospective Studies, Bile Duct Neoplasms surgery, Biliary Tract Neoplasms surgery, Cholangiocarcinoma
- Abstract
Background: This study aimed to investigate the impact of surgery on outcomes in patients with recurrent biliary tract cancer (BTC) and elucidate factors affecting survival after surgery for this disease., Methods: A single-center study was undertaken in 178 patients with recurrent BTC, of whom 24 underwent surgery for recurrence, 85 received chemotherapy, and 69 received best supportive care. Then, we carried out a multicenter study in 52 patients undergoing surgery for recurrent BTC (gallbladder cancer, 39%; distal cholangiocarcinoma, 27%; perihilar cholangiocarcinoma, 21%; intrahepatic cholangiocarcinoma, 13%)., Results: In the single-center study, 3-year survival after recurrence was 53% in patients who underwent surgery, 4% in those who received chemotherapy, and 0% in those who received best supportive care (p < 0.001). Surgery was an independently prognostic factor (p < 0.001). In the multicenter series, the respective 3-year and 5-year survival after surgery for recurrence was 50% and 29% in the 52 patients. Initial site of recurrence was the only independent prognostic factor (p = 0.019). Five-year survival after surgery for recurrence in patients with single distant, multifocal distant, and locoregional recurrence was 51%, 0%, and 0%, respectively (p = 0.002). Sites of single distant recurrence included the liver (n = 13, 54%), distant lymph nodes (all from gallbladder cancer, n = 7, 29%), lung (n = 2, 9%), peritoneum (n = 1, 4%), and abdominal wall (n = 1, 4%)., Conclusion: Surgery may be an effective option for patients with less aggressive tumor biology characterized by single distant recurrence in recurrent BTC., (Copyright © 2021 International Hepato-Pancreato-Biliary Association Inc. Published by Elsevier Ltd. All rights reserved.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.